In clinical research, some of the fundamental ethical issues that arise are the issues of exploitation, induced consent and an exposure of a research participant to an unjustifiable risk. If a pharma company deploys researchers from America to Nigeria with the aim of testing a trial drug that would be used to cure cancer, can this be an act of exploitation? What of if the participants were given some incentives before they were involved in the research protocols, could this be interpreted as a kind of inducement? How can these questions be addressed with the principle of equal moral consideration and human rights?